D.E. Shaw & Co’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-132,752
Closed -$4.01M 3721
2016
Q2
$4.01M Buy
+132,752
New +$2.69M 0.01% 1420

D.E. Shaw & Co's CPXX Position: Q3 2016 in Review

D.E. Shaw & Co sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 132,752 shares — an estimated $4.01M sold.

D.E. Shaw & Co first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $4.01M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • D.E. Shaw & Co reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 132,752 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $4.01M.
  • D.E. Shaw & Co first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • D.E. Shaw & Co's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $4.01M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.